Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018

Exp Dermatol. 2019 Jul;28(7):769-775. doi: 10.1111/exd.13928. Epub 2019 Apr 29.

Abstract

The 3rd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 12-14 October 2018 at the Women's College Hospital in Toronto, Ontario, Canada. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF) founded in the USA and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This cross-disciplinary meeting with experts from around the world was an opportunity to discuss the most recent advances in the study of hidradenitis suppurativa pathogenesis, epidemiology, classification, scoring systems, radiologic diagnosis, treatment approaches and psychologic assessment. Two special sessions this year were HS as a systemic disease and HS management guidelines. There were focused workshops on wound healing and ultrasound. There were two sessions primarily for patients and their families in the HS School programme: One workshop focused on mindfulness, and the second involved discussion among clinicians and patients about various disease aspects and the latest management. To facilitate networking between clinical and research experts and those early in their career, a mentoring breakfast was held.

Keywords: classification; diagnosis; epidemiology; pathogenesis; treatment.

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Canada
  • Dermatology / organization & administration
  • Dermatology / trends*
  • Hidradenitis Suppurativa / diagnosis*
  • Hidradenitis Suppurativa / epidemiology
  • Hidradenitis Suppurativa / therapy*
  • Humans
  • MicroRNAs
  • Phenotype
  • Pruritus
  • Quality of Life
  • Treatment Outcome
  • United States
  • Wound Healing

Substances

  • MicroRNAs